Business · 01/11/2002

FDA Withdraws 180-Day Exclusivity Rule for Generic Drug Applications

The US Food and Drug Administration (FDA) has withdrawn a proposed rule from 1999 that would have changed the regulations governing 180-day exclusivity for generic drug applications, following court decisions that affected the agency's previous interpretation of the Federal Food, Drug, and Cosmetic Act.